Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $244.54 and last traded at $244.54, with a volume of 40 shares. The stock had previously closed at $261.27.
Bio-Rad Laboratories Stock Performance
The company has a current ratio of 3.21, a quick ratio of 2.37 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $6.76 billion, a PE ratio of 41.64 and a beta of 0.96. The firm’s fifty day moving average price is $275.11 and its 200 day moving average price is $293.25.
Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.89 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a return on equity of 3.56% and a net margin of 6.52%.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.
In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.
Featured Articles
- Five stocks we like better than Bio-Rad Laboratories
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
- The Great SPR Arbitrage: An Oil Market Glitch Fuels Sector Gains
- Why Satellogic Could Be One of the Biggest Space Winners of 2026
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
